Among the down-regulated genes with LTR-001 stands SMYD3, which encodes a lysine methyltransferase involved in the methylation of MAP3K2, increasing MAP kinase signaling and promoting the formation of Ras-driven carcinomas (Hamamoto et al. 2004; Mazur et al. 2014). This evidence concerns the gene MAP3K2 and carcinoma.